Abstract

BackgroundNew information from various clinical settings suggests that tight blood pressure control may not reduce mortality and may be associated with more side effects.MethodsWe performed cross-sectional multivariable ordered logistic regression to examine the association between predialysis blood pressure and the short physical performance battery (SPPB) in a cohort of 749 prevalent hemodialysis patients in the San Francisco and Atlanta areas recruited from July 2009 to August 2011 to study the relationship between systolic blood pressure and objective measures of physical function. Mean blood pressure for three hemodialysis sessions was analyzed in the following categories: <110 mmHg, 110-129 mmHg (reference), 130-159 mmHg, and ≥160 mmHg. SPPB includes three components: timed repeated chair stands, timed 15-ft walk, and balance tests. SPPB was categorized into ordinal groups (≤6, 7-9, 10-12) based on prior literature.ResultsPatients with blood pressure 130-159 mmHg had lower odds (OR 0.57, 95% CI 0.35-0.93) of scoring in a lower SPPB category than those whose blood pressure was between 110 and 129 mmHg, while those with blood pressure ≥160 mmHg had 0.56 times odds (95% CI 0.33-0.94) of scoring in a lower category when compared with blood pressure 110-129 mmHg. When individual components were examined, blood pressure was significantly associated with chair stand (130-159 mmHg: OR 0.59, 95% CI 0.38-0.92) and gait speed (≥160 mmHg: OR 0.59, 95% CI 0.35-0.98). Blood pressure ≥160 mmHg was not associated with substantially higher SPPB score compared with 130-159 mmHg.ConclusionsPatients with systolic blood pressure at or above 130 mmHg had better physical performance than patients with lower blood pressure in the normotensive range. The risk-benefit tradeoff of aggressive blood pressure control, particularly in low-functioning patients, should be reexamined.

Highlights

  • New information from various clinical settings suggests that tight blood pressure control may not reduce mortality and may be associated with more side effects

  • The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial showed more adverse events among patients with diabetes randomly assigned to a systolic blood pressure target of

  • The odds ratio of scoring in a lower short physical performance battery (SPPB) category (0-6) was 0.60 for participants with a predialysis mean systolic blood pressure of ≥160 mmHg when compared with the reference range of 110-129 mmHg in univariate analysis

Read more

Summary

Introduction

New information from various clinical settings suggests that tight blood pressure control may not reduce mortality and may be associated with more side effects. The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial showed more adverse events among patients with diabetes randomly assigned to a systolic blood pressure target of

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call